- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06874517
Second Toe Length and Hallux Valgus: Greek vs. Egyptian Foot
March 22, 2025 updated by: Busra Sirin, Beylikduzu State Hospital
Greek vs. Egyptian Foot: The Impact of Second Toe Length on Hallux Valgus Development
A total of 150 patients aged 60-80 years with existing foot radiographs will be included in the study.
Radiographic evaluations will include measurements of the hallux valgus angle, first intermetatarsal angle, and the metatarsal and phalanx lengths of the first and second toes.
The ratio of the second toe phalanx length to the first toe phalanx length will be calculated and recorded.
The relationship between the hallux valgus angle, toe lengths, and their ratios will be analyzed using statistical methods.
Study Overview
Study Type
Observational
Enrollment (Estimated)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beylikdüzü
-
Istanbul, Beylikdüzü, Turkey, 34147
- Recruiting
- Beylikduzu State Hospital
-
Principal Investigator:
- Büşra Şirin Ahısha, MD
-
Contact:
- Büşra Şirin
- Phone Number: 02124443322
- Email: bsrn080@gmail.com
-
Sub-Investigator:
- Nurdan Paker, Prof
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
The study population will consist of 150 patients aged 60-80 years who have existing foot radiographs suitable for measurement.
Description
Inclusion Criteria:
- Age between 60-80 years
- Presence of foot radiographs suitable for measurement
- No history of prior foot surgery
Exclusion Criteria:
- History of foot trauma or fractures
- Previous foot or toe surgery
- Presence of congenital foot deformities
- Neurological or rheumatologic conditions affecting foot structure
- Severe osteoarthritis or other degenerative foot diseases visible on radiographs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hallux Valgus Angle
Time Frame: 0 day
|
The angle between the first metatarsal and the proximal phalanx of the first toe, measured on radiographs.
Higher values indicate greater hallux valgus severity.
|
0 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
First Intermetatarsal Angle
Time Frame: 0 day
|
The angle between the first and second metatarsal bones, measured on radiographs.
Higher values are associated with increased deformity.
|
0 day
|
|
First Toe (Hallux) Metatarsal and Phalanx Lengths
Time Frame: 0 day
|
The length of the first metatarsal and its phalanges, measured on radiographs.
|
0 day
|
|
Second Toe Metatarsal and Phalanx Lengths
Time Frame: 0 day
|
The length of the second metatarsal and its phalanges, measured on radiographs.
|
0 day
|
|
Second Toe to First Toe Phalanx Length Ratio
Time Frame: 0 day
|
The ratio of the second toe phalanx length to the first toe phalanx length, calculated to assess relative toe length differences.
|
0 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 10, 2025
Primary Completion (Estimated)
April 10, 2025
Study Completion (Estimated)
April 10, 2025
Study Registration Dates
First Submitted
March 8, 2025
First Submitted That Met QC Criteria
March 8, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Estimated)
March 26, 2025
Last Update Submitted That Met QC Criteria
March 22, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BeylikduzuStateH15
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.